| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-10 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-07 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.49 | 0.0001 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.5 | 0.0003 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.45 | 0.002 |